Overview
Trigeminal autonomic cephalalgia (TAC) refers to a group of primary headache disorders characterized by unilateral head pain occurring in the distribution of the trigeminal nerve, accompanied by prominent ipsilateral cranial autonomic features. This group includes cluster headache, paroxysmal hemicrania, short-lasting unilateral neuralgiform headache attacks (SUNCT/SUNA), and hemicrania continua. The autonomic symptoms that accompany the headache attacks include conjunctival injection (eye redness), lacrimation (tearing), nasal congestion or rhinorrhea, eyelid edema, forehead and facial sweating, miosis (pupil constriction), and ptosis (drooping eyelid), all occurring on the same side as the pain. The underlying pathophysiology involves activation of the trigeminovascular system and the trigeminal-autonomic reflex, with involvement of the hypothalamus playing a central role, particularly in the circadian and circannual periodicity seen in cluster headache. The pain is typically severe to excruciating and can be debilitating, significantly affecting quality of life. TACs primarily affect the nervous system, specifically the trigeminal sensory pathways and parasympathetic autonomic pathways. Treatment varies depending on the specific TAC subtype. Cluster headache is treated acutely with high-flow oxygen and subcutaneous sumatriptan, with verapamil being the most commonly used preventive agent. Paroxysmal hemicrania shows an absolute response to indomethacin, which is considered a diagnostic criterion. SUNCT/SUNA may respond to lamotrigine, and hemicrania continua also responds to indomethacin. Greater occipital nerve blocks and, in refractory cases, neurostimulation techniques (such as occipital nerve stimulation or sphenopalatine ganglion stimulation) may be considered. Early and accurate diagnosis is essential, as each subtype has distinct treatment approaches.
Multifactorial
Caused by a mix of several genes and environmental factors
Adult
Begins in adulthood (age 18 or older)
FDA & Trial Timeline
10 eventsSalvia BioElectronics — NA
Karolinska Institutet — NA
Beijing Tiantan Hospital
Radboud University Medical Center — PHASE2
Assistance Publique Hopitaux De Marseille — NA
Nanfang Hospital, Southern Medical University — NA
Power Life Sciences Inc.
Salvia BioElectronics — NA
Campus Bio-Medico University — NA
IRCCS National Neurological Institute "C. Mondino" Foundation
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Trigeminal autonomic cephalalgia.
1 clinical trialare actively recruiting — trials can provide access to cutting-edge therapies.
View clinical trials →Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Trigeminal autonomic cephalalgia.
Community
No community posts yet. Be the first to share your experience with Trigeminal autonomic cephalalgia.
Start the conversation →Latest news about Trigeminal autonomic cephalalgia
Disease timeline:
New recruiting trial: LSD to Improve Cluster Headache Impact Trial
A new clinical trial is recruiting patients for Trigeminal autonomic cephalalgia
New recruiting trial: nVNS for the Prevention and Treatment of Primary Headache
A new clinical trial is recruiting patients for Trigeminal autonomic cephalalgia
New recruiting trial: Yogabased Movements for Primary Headaches (Migraine and/or Cluster Headache) - YOURHEAD - a Pilot Study
A new clinical trial is recruiting patients for Trigeminal autonomic cephalalgia
New recruiting trial: Lysergic Acid Diethylamide (LSD) as Treatment for Cluster Headache
A new clinical trial is recruiting patients for Trigeminal autonomic cephalalgia
New recruiting trial: Repeated GON Injections in CCH
A new clinical trial is recruiting patients for Trigeminal autonomic cephalalgia
New recruiting trial: Botulinum Toxin Type A Blockade of the Sphenopalatine Ganglion in Treatment-refractory Chronic Cluster Headache
A new clinical trial is recruiting patients for Trigeminal autonomic cephalalgia
New recruiting trial: Ketamine + Magnesium for Chronic Cluster Headache (KETALGIA)
A new clinical trial is recruiting patients for Trigeminal autonomic cephalalgia
New recruiting trial: Efficacy of Light Therapy in Treatment of Chronic Cluster Headache
A new clinical trial is recruiting patients for Trigeminal autonomic cephalalgia
New recruiting trial: Response to Combined Trigeminal and Occipital Nerve Stimulation for the Preventive Treatment in Chronic Cluster Headache
A new clinical trial is recruiting patients for Trigeminal autonomic cephalalgia
New recruiting trial: China Headache and Vertigo Registry Study
A new clinical trial is recruiting patients for Trigeminal autonomic cephalalgia
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Trigeminal autonomic cephalalgia
What is Trigeminal autonomic cephalalgia?
Trigeminal autonomic cephalalgia (TAC) refers to a group of primary headache disorders characterized by unilateral head pain occurring in the distribution of the trigeminal nerve, accompanied by prominent ipsilateral cranial autonomic features. This group includes cluster headache, paroxysmal hemicrania, short-lasting unilateral neuralgiform headache attacks (SUNCT/SUNA), and hemicrania continua. The autonomic symptoms that accompany the headache attacks include conjunctival injection (eye redness), lacrimation (tearing), nasal congestion or rhinorrhea, eyelid edema, forehead and facial sweati
How is Trigeminal autonomic cephalalgia inherited?
Trigeminal autonomic cephalalgia follows a multifactorial inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Trigeminal autonomic cephalalgia typically begin?
Typical onset of Trigeminal autonomic cephalalgia is adult. Age of onset can vary across affected individuals.
Are there clinical trials for Trigeminal autonomic cephalalgia?
Yes — 1 recruiting clinical trial is currently listed for Trigeminal autonomic cephalalgia on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.
Which specialists treat Trigeminal autonomic cephalalgia?
25 specialists and care centers treating Trigeminal autonomic cephalalgia are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.